The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area  Edmund G. Lowrie, Zhensheng Li, Norma Ofsthun,

Slides:



Advertisements
Similar presentations
1 Chapter FIGURE 11.1 Normal densities for male and for female femoral circumferences (in millimeters). The summary statistics for drawing these.
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Michael Allon, Michelle L. Robbin  Kidney International 
Low Testosterone Levels and Reduced Kidney Function in Japanese Adult Men: The Locomotive Syndrome and Health Outcome in Aizu Cohort Study  Noriaki Kurita,
Improved prognosis of diabetic nephropathy in type 1 diabetes
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Central venous catheter outcomes in nocturnal hemodialysis
Volume 77, Issue 12, Pages (June 2010)
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Volume 64, Issue 4, Pages (October 2003)
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients  Maurizio Postorino, Carmen.
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Penetrance of Polygenic Obesity Susceptibility Loci across the Body Mass Index Distribution  Arkan Abadi, Akram Alyass, Sebastien Robiou du Pont, Ben.
The risk of hospitalization and modality failure with home dialysis
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint  D.R. VanDevanter, A. Yegin, W.J. Morgan,
Thomas F. O’Donnell, MD, Joseph Lau, MD  Journal of Vascular Surgery 
Volume 111, Issue 2, Pages (July 2016)
Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.
Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie 
Volume 79, Issue 12, Pages (June 2011)
Volume 66, Issue 3, Pages (September 2004)
Volume 68, Issue 6, Pages (December 2005)
Volume 56, Issue 2, Pages (August 1999)
Gabriel Loor, MD, Liang Li, PhD, Joseph F
Dietary phosphorus is associated with greater left ventricular mass
Survival advantage in Asian American end-stage renal disease patients1
Volume 77, Issue 7, Pages (April 2010)
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia  Blair S. Grace, Philip A. Clayton, Alan.
Edmund G. Lowrie  Kidney International 
Kt/V underestimates the hemodialysis dose in women and small men
American Journal of Kidney Diseases
What Are the Odds? The Annals of Thoracic Surgery
U-shaped effect of eGFR and mortality
Volume 90, Issue 6, Pages (December 2016)
Volume 86, Issue 3, Pages (September 2014)
Prescribing and monitoring hemodialysis dose
Volume 61, Issue 6, Pages (June 2002)
Intermediate survival in neonates with aortic atresia: A multi-institutional study  Marshall L. Jacobs, MD, Eugene H. Blackstone, MD, Leonard L. Bailey,
Helen Barraclough, MSc, Ramaswamy Govindan, MD 
Fredrik Elinder, Michael Madeja, Hugo Zeberg, Peter Århem 
Volume 61, Issue 1, Pages (January 2002)
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 73, Issue 8, Pages (April 2008)
Volume 84, Issue 4, Pages (October 2013)
Volume 65, Issue 4, Pages (April 2004)
Volume 67, Issue 5, Pages (May 2005)
Dialysis dose and gender: A different hypothesis
Volume 74, Issue 8, Pages (October 2008)
Volume 76, Issue 6, Pages (September 2009)
Volume 60, Issue 3, Pages (September 2001)
Robert G. Nelson, Hal Morgenstern, Peter H. Bennett 
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures  Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.
Volume 75, Issue 1, Pages (January 2009)
Manuel Prado, Laura M. Roa, Alfonso Palma, Jose A. Milen 
Changing hemodialysis thresholds for optimal survival
Volume 60, Issue 5, Pages (November 2001)
Volume 63, Pages S13-S16 (February 2003)
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Volume 87, Issue 3, Pages (March 2015)
Volume 61, Issue 2, Pages (February 2002)
Volume 77, Issue 12, Pages (June 2010)
Volume 66, Issue 4, Pages (October 2004)
Ivan D. Maya, Michael Allon  Kidney International 
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005  Donald R. VanDevanter, Eric P. Elkin,
Friends, social networks, and progressive chronic kidney disease
Central venous catheter outcomes in nocturnal hemodialysis
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area  Edmund G. Lowrie, Zhensheng Li, Norma Ofsthun, J. Michael Lazarus, M.D  Kidney International  Volume 68, Issue 3, Pages 1344-1354 (September 2005) DOI: 10.1111/j.1523-1755.2005.00533.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Risk profiles for deciles of BSA (left panel) and Kt (right panel) with and without statistical adjustments. CM adjustment means age, gender, race, and diabetic status. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Kt risk profiles for the quintiles of BSA showing log hazard (Y-axis) by the mean of the Kt octile (X-axis). These profiles were not adjusted for case mix. Case mix-adjusted profiles suggested similar relationships. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Death hazard fit curves by Kt target for the 1st, 2nd, 4th, and 5th quintiles of BSA. The best-fit target for the first through fifth quintiles were 42 L/treatment, 50, 55 (curve not shown), 51, and 56, respectively. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 The best-fit (reciprocal X) to Kt target for each BSA quintile by the mean of BSA for that quintile. The dark solid line is the best-fit relationship. The dashed lines indicate the 95% confidence interval for the regression. The standard error of estimates was 3.0 L/treatment, that is, 5.9% of the mean Kt at the mean BSA. See Table 2 for other regression statistics. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 The best-fit (reciprocal X) to Kt target for each BSA decile by the mean of BSA for that decile. The dark solid line is the best-fit relationship. The dashed lines indicate the 95% confidence interval for the regression. The standard error of estimates was 3.7 L/treatment, that is, 7.3% of the mean Kt at the mean BSA. See Table 2 for other regression statistics. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 The best-fit (double reciprocal) to Kt target for each BSA quintile and decile by the mean of BSA for that quintile or decile. The dark solid line is the best-fit relationship. The inner dashed lines indicate the 95% confidence interval for the regression. The standard error of estimates was 3.2 L/treatment, that is, 6.3% of the mean Kt at the mean BSA. See Table 2 for other regression statistics. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Comparison of extrapolated curves for the double reciprocal (thick, black curve), S-curve (thick, dark gray curve), reciprocal X (thin, gray curve), multiplicative (thick, light gray curve), and log X (thin, black curve) forms. The linear form for these data is also shown (thin, dash—dot—dash line). A linear, 0-intercept form taken from a regression of the mean BSA and mean Kt for males and females in the standard treatment arm of the HEMO study30 through the 0,0 origin is provided for comparison (thin, dashed line). The vertical arrows indicate the approximate 98% distribution interval of BSA. Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 The double reciprocal best-fit (black curve: R2 = 0.811, P < 0.04) and linear (gray line: R2 = 0.737, P = 0.06; Kt = 28.6 + [0.46 × BSA]) relationships for Kt target by volume of distribution (V) taken from data reported earlier26. A 0-intercept, linear relationship Kt = 0 + [1.2 × V] is shown for comparison (dashed line). Kidney International 2005 68, 1344-1354DOI: (10.1111/j.1523-1755.2005.00533.x) Copyright © 2005 International Society of Nephrology Terms and Conditions